Daniel M Spielman

Prof. Daniel M Spielman

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2009 in Magnetic Resonance in Medicine
Verified
Journal Article
Open access
PDF file
DSDaniel M Spielman
Daniel M Spielman
DMDirk Mayer
Dirk Mayer
YYYi‐Fen Yen
Yi‐Fen Yen
JTJames Tropp
James Tropp
RHRalph E. Hurd
Ralph E. Hurd
APAdolf Pfefferbaum
Adolf Pfefferbaum
[1‐13C]Pyruvate is a readily polarizable substrate that has been the subject of numerous magnetic resonance spectroscopy (MRS) studies of in vivo metabolism. In this work 13C‐MRS of hyperpolarized [1‐13C]pyruvate was used to interrogate a metabolic pathway involved in neither aerobic nor anaerobic metabolism. In particular, ethanol consumption leads to altered liver metabolism, which when excessive is associated with adverse medical conditions including fatty liver disease, hepatitis, cirrhosis, and cancer. Here we present a method for noninvasively monitoring this important process in vivo. Following the bolus injection of hyperpolarized [1‐13C]pyruvate, we demonstrate a significantly increased rat liver lactate production rate with the coadministration of ethanol (P = 0.0016 unpaired t‐test). The affect is attributable to increased liver nicotinamide adenine dinucleotide (NADH) associated with ethanol metabolism in combination with NADH's role as a coenzyme in pyruvate‐to‐lactate conversion. Beyond studies of liver metabolism, this novel in vivo assay of changes in NADH levels makes hyperpolarized [1‐13C]pyruvate a potentially viable substrate for studying the multiple in vivo metabolic pathways that use NADH (or NAD+) as a coenzyme, thus broadening the range of applications that have been discussed in the literature to date. Magn Reson Med, 2009.

28 April 2011 in NMR in Biomedicine
Verified
Journal Article
Closed access
PDF file
TXTao Xu
Tao Xu
DMDirk Mayer
Dirk Mayer
MGMeng Gu
Meng Gu
YYYi‐Fen Yen
Yi‐Fen Yen
SJSonal Josan
Sonal Josan
DSDaniel M Spielman
Daniel M Spielman

5 October 2023 in Magnetic Resonance in Medicine
Verified
Journal Article
Closed access
PAPhilip M. Adamson
Philip M. Adamson
KDKeshav Datta
Keshav Datta
RWRon Watkins
Ron Watkins
LRLawrence D. Recht
Lawrence D. Recht
RHRalph Hurd
Ralph Hurd
DSDaniel M Spielman
Daniel M Spielman

5 June 2017 in ACS Chemical Biology
Verified
Journal Article
Closed access
AWArif Wibowo
Arif Wibowo
JPJae Mo Park
Jae Mo Park
SLShie-Chau Liu
Shie-Chau Liu
CKChaitan Khosla
Chaitan Khosla
DSDaniel M Spielman
Daniel M Spielman

8 May 2017 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
JPJae Mo Park
Jae Mo Park
MWMarvin Wu
Marvin Wu
KDKeshav Datta
Keshav Datta
SLShie-Chau Liu
Shie-Chau Liu
ACAndrew Castillo
Andrew Castillo
KBKelvin L. Billingsley
Kelvin L. Billingsley

24 September 2009 in Magnetic Resonance in Medicine
Verified
Journal Article
Open access
PDF file
YLYakir S. Levin
Yakir S. Levin
MAMark J. Albers
Mark J. Albers
TBThomas N. Butler
Thomas N. Butler
DSDaniel M Spielman
Daniel M Spielman
DPDonna M. Peehl
Donna M. Peehl
JKJohn Kurhanewicz
John Kurhanewicz
Prostate cancer has been shown to undergo unique metabolic changes associated with neoplastic transformation, with associated changes in citrate, alanine, and lactate concentrations. 13C high resolution‐magic angle spinning (HR‐MAS) spectroscopy provides an opportunity to simultaneously investigate the metabolic pathways implicated in these changes by using 13C‐labeled substrates as metabolic probes. In this work, a method to reproducibly interrogate metabolism in prostate cancer cells in primary culture was developed using HR‐MAS spectroscopy. Optimization of cell culture protocols, labeling parameters, harvesting, storage, and transfer was performed. Using [3‐13C] pyruvate as a metabolic probe, 1H and 13C HR‐MAS spectroscopy was used to quantify the net amount and fractional enrichment of several labeled metabolites that evolved in multiple cell samples from each of five different prostate cancers. Average enrichment across all cancers was 32.4 ± 5.4% for [3‐13C] alanine, 24.5 ± 5.4% for [4‐13C] glutamate, 9.1 ± 2.5% for [3‐13C] glutamate, 25.2 ± 5.7% for [3‐13C] aspartate, and 4.2 ± 1.0% for [3‐13C] lactate. Cell samples from the same parent population demonstrated reproducible fractional enrichments of alanine, glutamate, and aspartate to within 12%, 10%, and 10%, respectively. Furthermore, the cells produced a significant amount of [4‐13C] glutamate, which supports the bioenergetic theory for prostate cancer. These methods will allow further characterization of metabolic properties of prostate cancer cells in the future. Magn Reson Med, 2009.